Melior Discovery Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$294K
- Investors
-
11
Melior Discovery General Information
Description
Developer of in vivo pharmacology intended to identify indications for pre-clinical and development-stage drug candidates. The company specializes in offering rapid and cost-effective identification of new therapeutic potential by systematically screening candidates in a diverse array of validated in vivo disease models, enabling clients to get bioanalytical testing products.
Contact Information
Website
www.meliordiscovery.comCorporate Office
- 860 Springdale Drive
- Suite 500
- Exton, PA 19341
- United States
Corporate Office
- 860 Springdale Drive
- Suite 500
- Exton, PA 19341
- United States
Melior Discovery Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Debt - PPP | 13-Apr-2020 | $294K | Completed | Generating Revenue | ||
| 8. Grant | 11-Dec-2014 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 06-Feb-2013 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A) | 07-Oct-2011 | Completed | Generating Revenue | |||
| 5. Grant | 16-Aug-2011 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 23-Sep-2009 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 19-Jun-2007 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 01-Apr-2006 | $2.5M | $3M | Completed | Startup | |
| 1. Seed Round | 25-Jan-2005 | $500K | $500K | Completed | Startup |
Melior Discovery Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Melior Discovery Comparisons
Industry
Financing
Details
Melior Discovery Competitors (6)
One of Melior Discovery’s 6 competitors is StageBio, a Private Equity-Backed company based in Frederick, MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| StageBio | Private Equity-Backed | Frederick, MD | ||||
| Psychogenics | Private Debt Financed | Paramus, NJ | ||||
| Alturas Analytics | Corporation | Moscow, ID | ||||
| Empire Genomics | Formerly PE-Backed | Depew, NY | ||||
| HistologiX | Corporate Backed or Acquired | Nottingham, United Kingdom |
Melior Discovery Patents
Melior Discovery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220031700-A1 | Treatment of acute respiratory distress syndrome (ards) | Inactive | 30-Jul-2020 | ||
| WO-2022026645-A1 | Treatment of acute respiratory distress syndrome (ards) | Inactive | 30-Jul-2020 | ||
| AU-2019223911-A1 | Treatment of liver diseases | Inactive | 21-Feb-2018 | ||
| CA-3088178-A1 | Treatment of liver diseases | Pending | 21-Feb-2018 | ||
| EP-3755334-A1 | Treatment of liver diseases | Inactive | 21-Feb-2018 | A61K31/513 |
Melior Discovery Signals
Melior Discovery Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases | Government | |||
| Angel (individual) | Minority | |||
| EarlyStage.nyc Fund | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Michael J. Fox Foundation | Limited Partner |
Melior Discovery Acquisitions (1)
Melior Discovery’s most recent deal was a Merger/Acquisition with Biolucidation. The deal was made on 09-Jul-2013.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biolucidation | 09-Jul-2013 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Melior Discovery FAQs
-
When was Melior Discovery founded?
Melior Discovery was founded in 2005.
-
Where is Melior Discovery headquartered?
Melior Discovery is headquartered in Exton, PA.
-
What is the size of Melior Discovery?
Melior Discovery has 24 total employees.
-
What industry is Melior Discovery in?
Melior Discovery’s primary industry is Drug Discovery.
-
Is Melior Discovery a private or public company?
Melior Discovery is a Private company.
-
What is Melior Discovery’s current revenue?
The current revenue for Melior Discovery is .
-
How much funding has Melior Discovery raised over time?
Melior Discovery has raised $8.69M.
-
Who are Melior Discovery’s investors?
National Institute of Diabetes and Digestive and Kidney Diseases, , EarlyStage.nyc Fund, , and Michael J. Fox Foundation are 5 of 11 investors who have invested in Melior Discovery.
-
Who are Melior Discovery’s competitors?
StageBio, Psychogenics, Alturas Analytics, Empire Genomics, and HistologiX are some of the 6 competitors of Melior Discovery.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process